Global Information
회사소개 | 문의 | 위시리스트

세계의 바이러스 제거 시장 : 인사이트, 시장 기회, 분석, 시장 점유율, 예측

Global Virus Filteration Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2024

리서치사 Occams Business Research & Consulting Pvt. Ltd.
발행일 발행예정 상품 코드 621140
페이지 정보 영문
가격
US $ 5,000 ₩ 5,995,000 PDF by E-mail (Single User License)
US $ 7,000 ₩ 8,393,000 PDF by E-mail (Enterprise License)


세계의 바이러스 제거 시장 : 인사이트, 시장 기회, 분석, 시장 점유율, 예측 Global Virus Filteration Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2024
발행일 : 발행예정 페이지 정보 : 영문

세계의 바이러스 제거(Virus Filteration) 시장에 대해 조사했으며, 산업 및 시장 개요, 제품 종류·기술·용도·최종사용자·지역별 시장 동향, 시장 규모 추이와 예측, 시장 성장 촉진요인 저해요인, 시장 기회와 과제, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 조사 개요

  • 세계의 바이러스 제거 시장 : 발전과 변화
  • 시장 정의와 범위
  • 산업 구조
  • 시장 분석
  • 예측 분석
  • 전략 분석
    • 투자 vs.도입 모델
    • 전방위적 산업 분석
    • Five Forces 분석
    • SEE SAW 분석
    • 소비자 분석과 주요 구매 기준
  • 경쟁 분석
    • 주요 전략과 분석
    • 시장 점유율 및 주요 기업 분석
  • 전략 제안과 주요 결론
    • 지역별 투자 기회
    • 신규 분야의 시장 기회
    • 급성장 시장의 투자 기회

제3장 시장 결정요인

  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회
  • 해결해야 할 과제

제4장 시장 세분화

  • 바이러스 제거 시장 : 제품 종류별
    • 소모품
    • 기기
    • 서비스
  • 바이러스 제거 시장 : 기술별
    • 필터
    • 크로마토그래피
  • 바이러스 제거 시장 : 용도별
    • 생물학적 제제
    • 의료기기
    • 정수
    • 공기청정
  • 바이러스 제거 시장 : 최종사용자별
    • 바이오 제약 및 바이오테크놀러지 기업
    • 임상시험 수탁기관(CRO)
    • 의료기기 제조업체
    • 학술연구기관

제5장 경쟁 구도

  • 주요 전략
    • 인수합병 리스트
    • 합작투자 리스트
    • 발매 제품 리스트
    • 사업 제휴 리스트

제6장 지역 분석

  • 의사 지원 결정 데이터베이스 및 추정 방법
  • 시장 부문 비교 분석
  • 시장 기회 매트릭스
  • 지역별
    • 북미(미국, 캐나다)
    • 유럽(영국, 프랑스, 독일, 스페인 등)
    • 아시아태평양(중국, 인도, 일본, 호주 등)
    • 기타 지역(라틴아메리카, 중동 및 아프리카)

제7장 기업 개요

  • ARGONIDE
  • ASAHI KASEI MEDICAL CO., LTD.
  • CHARLES RIVER LABORATORIES
  • CLEAN CELLS INC.
  • DANAHER CORPORATION
  • GE HEALTHCARE
  • LENNTECH
  • LONZA GROUP
  • MERCK GROUP
  • PENDOTECH
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC
  • WUXI PHARMATECH(CAYMAN) INC.
LSH 18.04.13

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • 1. GLOBAL VIRUS FILTRATION MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 2. GLOBAL CONSUMABLES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL VIRUS FILTRATION MARKET BY CONSUMABLES 2014-2023 ($ MILLION)
  • 4. GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL VIRUS FILTRATION MARKET BY INSTRUMENTS 2014-2023 ($ MILLION)
  • 6. GLOBAL SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL VIRUS FILTRATION MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
  • 8. GLOBAL FILTRATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBALCHROMATOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL VIRUS FILTRATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 11. GLOBAL BIOLOGICALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL VIRUS FILTRATION MARKET BY BIOLOGICALS 2014-2023 ($ MILLION)
  • 13. GLOBAL MEDICAL DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL WATER PURIFICATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL AIR PURIFICATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. GLOBAL VIRUS FILTRATION MARKET BY END USERS 2014-2023 ($ MILLION)
  • 17. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 18. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 19. GLOBAL MEDICAL DEVICES COMPANIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL ACADEMIC INSTITUTES & RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. NORTH AMERICA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 22. EUROPE VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 23. ASIA PACIFIC VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 24. REST OF THE WORLD VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CONSUMABLESMARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL KITS AND REAGENTSMARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL OTHERSMARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL INSTRUMENTSMARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL FILTRATION SYSTEMSMARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL CHROMATOGRAPHY SYSTEMSMARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL SERVICESMARKET 2014-2023 ($ MILLION)
  • 8. GLOBAL FILTRATIONMARKET 2014-2023 ($ MILLION)
  • 9. GLOBAL CHROMATOGRAPHYMARKET 2014-2023 ($ MILLION)
  • 10. GLOBAL BIOLOGICALMARKET 2014-2023 ($ MILLION)
  • 11. GLOBAL VACCINES AND THERAPEUTICSMARKET 2014-2023 ($ MILLION)
  • 12. GLOBAL BLOOD AND BLOOD PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 13. GLOBAL CELLULAR AND GENE THERAPY PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 14. GLOBAL TISSUE AND TISSUE PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 15. GLOBAL STEM CELL PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 16. GLOBAL MEDICAL DEVICESMARKET 2014-2023 ($ MILLION)
  • 17. GLOBAL WATER PURIFICATIONMARKET 2014-2023 ($ MILLION)
  • 18. GLOBAL AIR PURIFICATIONMARKET 2014-2023 ($ MILLION)
  • 19. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIESMARKET 2014-2023 ($ MILLION)
  • 20. GLOBAL CONTRACT RESEARCH ORGANIZATIONSMARKET 2014-2023 ($ MILLION)
  • 21. GLOBAL MEDICAL DEVICES COMPANIESMARKET 2014-2023 ($ MILLION)
  • 22. GLOBAL ACADEMIC INSTITUTES & RESEARCH LABORATORIESMARKET 2014-2023 ($ MILLION)
  • 23. UNITED STATES (U.S.) VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 24. CANADA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 25. UNITED KINGDOM (UK) VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 26. FRANCE VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 27. GERMANY VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 28. SPAIN VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 29. ROE VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 30. INDIA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 31. CHINA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 32. JAPAN VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 33. AUSTRALIA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 34. ROAPAC VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 35. LATIN AMERICA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 36. MENA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)

Virus filtration technology is majorly used for removal of viruses such as tailed viruses, deformable bacteria, etc. The global virus filtration market is expected to rise with the CAGR of about 12% during forecast period. Rising demand for biological products such as vaccines, cellular & gene therapy, etc. is one of the major factor which contributes to growth of global virus filtration market during forecast period. Also, growth in pharmaceutical industry as well as rise in research &development in biologic contributes to the market growth. However, stringent regulations for validation of filtration products and highly consolidated market are the factors restraining growth of virus filtration market during forecast period.

Geographically, North America accounted for the largest market share in terms of revenue in 2016 for the virus filtration market followed by Asia Pacific and Europe. North America is expected to dominate the market in terms of revenue during the forecast period due to growth of pharmaceutical industry across the region. However, Asia Pacific is expected to be the fastest growing region in terms of revenue in virus filtration market during the forecast period. Highest growth rate in Asia Pacific virus filtration market is majorly witnessed due to increasing pharmaceutical outsourcing in Asia Pacific during the forecast period.

The growth in global virus filtration market is also influenced by the presence of major players such asMerck group (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific (U.S.), Wuxi Pharmatech (Cayman) Inc. (China), etc. Product launches, mergers & acquisitions, joint ventures, collaboration etc. are some crucial strategies that are adopted by the major players to gain competitive advantage.

Global virus filtration market report covers segmentation analysis of product, technology, application and end users. Report further covers segments of product which include consumables, instruments and services. Consumables accounted for the largest market revenue share in 2016 and it is expected to dominate the market during the forecast period due to increased usage of consumables such as reagents, membranes, etc. in biologic downstream processing. Technologies involved in virus filtration include filtration and chromatography. Further, applications of virus filtration include biological, medical devices, water purification and air purification. Chromatography is expected to be the fastest growing segment during the forecast period due to advancements in product such as development of singleuse membranes. Furthermore, the end users adopting virus filtration include biopharmaceutical & biotechnology companies, contract research organizations, medical devices companies and academic institutes & research laboratories.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL VIRUS FILTRATION MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. GROWTH IN PHARMACEUTICAL INDUSTRY
    • 3.1.2. RISE IN R&D IN BIOLOGIC
    • 3.1.3. GOVERNMENT SUPPORT FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
    • 3.1.4. INCREASING DEMAND FOR BIOLOGICAL PRODUCTS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. STRINGENT REGULATIONS FOR VALIDATION OF FILTRATION PRODUCTS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING ADOPTION OF SINGLE-USE TECHNOLOGIES
    • 3.3.2. INCREASING PHARMACEUTICAL OUTSOURCING
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGHLY CONSOLIDATED MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL VIRUS FILTRATION MARKET BY TYPE OF PRODUCT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBALCONSUMABLESMARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
        • 4.1.5.1.5. MARKET SUB-SEGMENTS
          • 4.1.5.1.5.1. KITS AND REAGENTS
          • 4.1.5.1.5.2. OTHERS
      • 4.1.5.2. GLOBAL INSTRUMENTSMARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
        • 4.1.5.2.5. MARKET SUB-SEGMENTS
          • 4.1.5.2.5.1. FILTRATION SYSTEMS
          • 4.1.5.2.5.2. CHROMATOGRAPHY SYSTEMS
      • 4.1.5.3. GLOBAL SERVICESMARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
  • 4.2. GLOBAL VIRUS FILTRATION MARKET BY TECHNOLOGY
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBALFILTRATION MARKET
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.4. KEY CONCLUSIONS
      • 4.2.5.2. GLOBALCHROMATOGRAPHY MARKET
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.4. KEY CONCLUSIONS
  • 4.3. GLOBAL VIRUS FILTRATION MARKET BY APPLICATION
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBALBIOLOGICALMARKET
        • 4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.4. KEY CONCLUSIONS
        • 4.3.5.1.5. MARKET SUB-SEGMENTS
          • 4.3.5.1.5.1. VACCINES AND THERAPEUTICS
          • 4.3.5.1.5.2. BLOOD AND BLOOD PRODUCTS
          • 4.3.5.1.5.3. CELLULAR AND GENE THERAPY PRODUCTS
          • 4.3.5.1.5.4. TISSUE AND TISSUE PRODUCTS
          • 4.3.5.1.5.5. STEM CELL PRODUCTS
      • 4.3.5.2. GLOBALMEDICAL DEVICES MARKET
        • 4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.4. KEY CONCLUSIONS
      • 4.3.5.3. GLOBALWATER PURIFICATION MARKET
        • 4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.3.4. KEY CONCLUSIONS
      • 4.3.5.4. GLOBALAIR PURIFICATIONMARKET
        • 4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.4.4. KEY CONCLUSIONS
  • 4.4. GLOBAL VIRUS FILTRATION MARKET BY END-USER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBALBIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.1.4. KEY CONCLUSIONS
      • 4.4.5.2. GLOBALCONTRACT RESEARCH ORGANIZATIONSMARKET
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.2.4. KEY CONCLUSIONS
      • 4.4.5.3. GLOBALMEDICAL DEVICES COMPANIESMARKET
        • 4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.3.4. KEY CONCLUSIONS
      • 4.4.5.4. GLOBALACADEMIC INSTITUTES & RESEARCH LABORATORIESMARKET
        • 4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.4.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS AND ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHIC ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL VIRUS FILTRATION MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ARGONIDE (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. ASAHI KASEI MEDICAL CO., LTD. (JAPAN)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. CHARLES RIVER LABORATORIES (U.S.)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. CLEAN CELLS INC. (FRANCE)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. DANAHER CORPORATION (U.S.)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. GE HEALTHCARE (U.K.)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. LENNTECH (THE NETHERLANDS)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. LONZA GROUP (SWITZERLAND)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. MERCK GROUP (GERMANY)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. PENDOTECH (U.S.)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. SARTORIUS AG (GERMANY)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. THERMO FISHER SCIENTIFIC (U.S.)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. WUXI PHARMATECH (CAYMAN) INC. (CHINA)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
Back to Top
전화 문의
F A Q